Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Saved in:
Bibliographic Details
Title: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
Authors: Perez, Edith A.1 (AUTHOR) Perez.edith@mayo.edu, de Haas, Sanne Lysbet2 (AUTHOR) sanne_lysbet.de_haas@roche.com, Eiermann, Wolfgang3 (AUTHOR) w.eiermann@gmx.net, Barrios, Carlos H.4 (AUTHOR) chbe@via-rs.net, Toi, Masakazu5 (AUTHOR) toi@kuhp.kyoto-u.ac.jp, Im, Young-Hyuck6 (AUTHOR) imyh00@skku.edu, Conte, Pier Franco7 (AUTHOR) Pierfranco.conte@unipd.it, Martin, Miguel8 (AUTHOR) mmartin@geicam.org, Pienkowski, Tadeusz9 (AUTHOR) tadeusz.pienkowski@gmail.com, Pivot, Xavier B.10 (AUTHOR) xpivot@strasbourg.unicancer.fr, Burris III, Howard A.11 (AUTHOR) Howard.Burris@scresearch.net, Stanzel, Sven2 (AUTHOR) sven_franz.stanzel@roche.com, Patre, Monika2 (AUTHOR) monika.patre@roche.com, Ellis, Paul Anthony12 (AUTHOR) paul@ellis-uk.org, Burris, Howard A 3rd13 (AUTHOR)
Source: BMC Cancer. 5/30/2019, Vol. 19 Issue 1, p1-14. 14p. 1 Diagram, 4 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-019-5687-0